Advancing gender equality in science is not only a matter of fairness, but it also directly improves public health, social policy, and innovation by embedding inclusion into how knowledge is produced and applied.

In recent weeks, health authorities in India’s state of West Bengal have confirmed cases of Nipah virus infection amid ongoing surveillance and containment efforts.

The MVPE-CC consortium contributed key evidence reviewed in a joint session of the WHO’s Strategic Advisory Group of Experts on Immunisation (SAGE) and Malaria Policy Advisory Group (MPAG) held in September 2025 for considerations of malaria vaccination schedules in perennial settings. The conclusions and recommendations of the SAGE and MPAG were published in the latest issue of the Weekly Epidemiological Record (No 49, 5 December 2025). December 2025 WHO has recommended two

A newly released video titled Proving the value of malaria vaccines: how case-control studies can guide immunisation strategies looks at the value of case control studies.

EVI is committed to supporting a development pathway that ensures the highest scientific standards from early optimisation through to field evaluation

This comprehensive analysis brings renewed attention to placental malaria (PM), a condition that continues to threaten millions of pregnant women and newborns globally. Drawing on 50 studies conducted since 2013, the review confirms that placental malaria remains highly prevalent in malaria-endemic regions.

On 24-25 November, EVI team members convened at the Woudschoten Conference Center for a two-day retreat focused on strategic alignment, operational updates, and team cohesion. Situated in the tranquil woods near Zeist, Woudschoten offered an ideal backdrop for reflection, collaboration, and a bit of woodland adventure: including a hands-on session that tested the team’s real-time cooperation and adaptation in a fun, yet unexpected setting.

Since welcoming the first fellow in 2015, EVI has supported early- and mid-career researchers from low- and middle-income countries in developing their skills across the vaccine development spectrum.

Vaccines play a vital, but sometimes underappreciated, role in the fight against AMR.